Hedge Fund - Baker Bros. Advisors
Acadia Pharmaceuticals Inc (ACAD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $1,342,091,002 | 15.27% | 42,864,612 | $23.88 |
| 2 | 2023 - Q3 (2023-09-30) | $893,298,514 | 5.14% | 42,864,612 | $27.16 |
| 3 | 2023 - Q2 (2023-06-30) | $1,026,607,457 | 5.94% | 42,864,612 | $22.23 |
| 4 | 2023 - Q1 (2023-03-31) | $789,282,307 | 4.29% | 41,938,486 | $19.05 |
| 5 | 2022 - Q4 (2022-12-31) | $667,421,897 | 4% | 41,923,486 | $15.63 |
| 6 | 2022 - Q3 (2022-09-30) | $685,868,000 | 4.49% | 41,923,486 | $16.19 |
| 7 | 2022 - Q2 (2022-06-30) | $590,702,000 | 3.35% | 41,923,486 | $18.68 |
| 8 | 2022 - Q1 (2022-03-31) | $1,015,077,000 | 5.83% | 41,910,704 | $24.20 |
| 9 | 2021 - Q4 (2021-12-31) | $978,196,000 | 4.75% | 41,910,704 | $20.11 |
| 10 | 2021 - Q3 (2021-09-30) | $696,137,000 | 3.05% | 41,910,704 | $19.28 |
| 11 | 2021 - Q2 (2021-06-30) | $1,022,202,000 | 4.48% | 41,910,704 | $22.57 |
| 12 | 2021 - Q1 (2021-03-31) | $1,081,296,000 | 4.68% | 41,910,704 | $44.02 |
| 13 | 2020 - Q4 (2020-12-31) | $2,240,219,000 | 8.43% | 41,904,586 | $49.64 |
| 14 | 2020 - Q3 (2020-09-30) | $1,728,564,000 | 6.9% | 41,904,586 | $43.18 |
| 15 | 2020 - Q2 (2020-06-30) | $2,031,115,000 | 8.95% | 41,904,586 | $48.00 |
| 16 | 2020 - Q1 (2020-03-31) | $1,770,469,000 | 10.9% | 41,904,586 | $41.20 |
| 17 | 2019 - Q4 (2019-12-31) | $1,747,759,000 | 9.29% | 40,854,586 | $43.50 |
| 18 | 2019 - Q3 (2019-09-30) | $1,470,357,000 | 10% | 40,854,586 | $30.32 |
| 19 | 2019 - Q2 (2019-06-30) | $1,050,277,000 | 7.13% | 39,292,086 | $25.54 |
| 20 | 2019 - Q1 (2019-03-31) | $1,066,317,000 | 6.82% | 39,713,842 | $23.35 |
| 21 | 2018 - Q4 (2018-12-31) | $642,173,000 | 5.25% | 39,713,842 | $19.42 |
| 22 | 2018 - Q3 (2018-09-30) | $590,396,000 | 3.88% | 28,439,114 | $15.73 |
| 23 | 2018 - Q2 (2018-06-30) | $415,777,000 | 3.12% | 27,228,338 | $17.83 |
| 24 | 2018 - Q1 (2018-03-31) | $611,821,000 | 5.18% | 27,228,338 | $27.69 |
| 25 | 2017 - Q4 (2017-12-31) | $819,845,000 | 7.1% | 27,228,338 | $31.98 |
| 26 | 2017 - Q3 (2017-09-30) | $972,631,000 | 7.88% | 25,819,768 | $32.53 |
| 27 | 2017 - Q2 (2017-06-30) | $720,113,000 | 6.29% | 25,819,768 | $29.80 |
| 28 | 2017 - Q1 (2017-03-31) | $887,684,000 | 7.26% | 25,819,768 | $35.30 |
| 29 | 2016 - Q4 (2016-12-31) | $744,642,000 | 7.29% | 25,819,768 | $26.46 |
| 30 | 2016 - Q3 (2016-09-30) | $821,327,000 | 7.45% | 25,819,768 | $33.90 |
| 31 | 2016 - Q2 (2016-06-30) | $795,813,000 | 8.34% | 24,516,738 | $33.47 |
| 32 | 2016 - Q1 (2016-03-31) | $677,019,000 | 7.13% | 24,213,838 | $21.84 |
| 33 | 2015 - Q4 (2015-12-31) | $730,163,000 | 6.04% | 20,481,442 | $35.23 |
| 34 | 2015 - Q3 (2015-09-30) | $677,321,000 | 6.25% | 20,481,442 | $41.61 |
| 35 | 2015 - Q2 (2015-06-30) | $857,763,000 | 7.52% | 20,481,442 | $38.70 |
| 36 | 2015 - Q1 (2015-03-31) | $667,490,000 | 5.55% | 20,481,442 | $34.37 |
| 37 | 2014 - Q4 (2014-12-31) | $650,286,000 | 6.63% | 20,481,442 | $28.36 |
| 38 | 2014 - Q3 (2014-09-30) | $507,121,000 | 6.38% | 20,481,442 | $23.39 |
| 39 | 2014 - Q2 (2014-06-30) | $462,676,000 | 5.66% | 20,481,442 | $20.88 |
| 40 | 2014 - Q1 (2014-03-31) | $498,313,000 | 6.33% | 20,481,442 | $25.30 |
| 41 | 2013 - Q4 (2013-12-31) | $498,679,000 | 7.02% | 19,955,126 | $23.59 |
| 42 | 2013 - Q3 (2013-09-30) | $548,167,000 | 7.79% | 19,955,126 | $20.91 |
| 43 | 2012 - Q3 (2012-09-30) | $13,273,000 | 0.29% | 5,246,312 | $1.85 |
| 44 | 2012 - Q1 (2012-03-31) | $11,280,000 | 0.3% | 5,246,312 | $1.68 |
| 45 | 2011 - Q4 (2011-12-31) | $5,666,000 | 0.18% | 5,246,312 | $1.09 |
| 46 | 2011 - Q3 (2011-09-30) | $5,666,000 | 0.24% | 5,246,312 | $1.45 |
| 47 | 2011 - Q2 (2011-06-30) | $7,114,000 | 0.27% | 4,364,420 | $1.97 |
| 48 | 2011 - Q1 (2011-03-31) | $7,070,000 | 0.29% | 4,364,070 | $1.61 |
| 49 | 2010 - Q4 (2010-12-31) | $211,000 | 0% | 175,588 | $0.83 |
The displayed share prices are average quarterly stock market prices.